Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lei

Showing results (171-180 of 262) with videos related to

Pageof 27
Sort By:
Nature Materials|June 13, 2017
Intrinsically patterned two-dimensional materials for selective adsorption of molecules and nanoclustersX Lin, J C Lu, Y Shao, et al.
Iscience|January 9, 2023
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, et al.
Cell Reports. Medicine|June 6, 2025
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J Jaehnig, Aranzazu Fernandez-Martinez, Tanmayi D Vashist, et al.
Cancer Cell|March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast CancerZe-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Cell|November 19, 2020
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted TherapyKarsten Krug, Eric J Jaehnig, Shankha Satpathy, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Pageof 27

Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
Nature Materials|June 13, 2017
Intrinsically patterned two-dimensional materials for selective adsorption of molecules and nanoclustersX Lin, J C Lu, Y Shao, et al.
Iscience|January 9, 2023
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, et al.
Cell Reports. Medicine|June 6, 2025
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J Jaehnig, Aranzazu Fernandez-Martinez, Tanmayi D Vashist, et al.
Cancer Cell|March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast CancerZe-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Cancer Discovery|August 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast CancerMeenakshi Anurag, Eric J Jaehnig, Karsten Krug, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Cell|November 19, 2020
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted TherapyKarsten Krug, Eric J Jaehnig, Shankha Satpathy, et al.
Arerugi = [Allergy]|September 20, 2023
M Maurer, M Magerl, S Betschel, et al.
Pageof 27